New registry data shows semaglutide does not cause pancreatic cancer
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows no link between semaglutide use and pancreatic cancer using nationwide registry data from Denmark, Sweden and Norway.
Read original article on The Medical News →Related news
-
Weapons worsen psychological harm in survivors of intimate partner violence, study finds
United Kingdom
-
Eye infections can steal sight, but early diagnosis can save vision
United Kingdom
-
Brain activity varies with age in children with autistic traits
United Kingdom
-
Neck lymph node removal linked to increased risk of cognitive decline
United Kingdom
-
Distinct gut microbiome patterns found in five cancer groups and in early-onset cancers
United Kingdom
-
First national estimate identifies nearly 110,000 medical cannabis caregivers
United Kingdom
-
Menthol enhances the strength and duration of nicotine's effects in rats
United Kingdom
-
Q&A: What are ultra-processed foods?
United Kingdom